Aarti Drugs share news, announcements and annual reports
NSE: AARTIDRUGSBSE: 524348Pharmaceuticals & BiotechnologySmall Cap
Aarti Drugs Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 1993 on BSE, Sep 2003 on NSE
Last close ₹435.20down ₹13.80 (3.07%)BSE ₹435.70
Share price at the NSE close on 30 Oct 2026. Previous close ₹449.00.
30 Oct: open ₹444.00, high ₹449.00, low ₹432.50
52-week range of traded prices to 30 Oct 2026
₹318.95Low, 30 Mar 2026₹534.00High, 10 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,972 Cr930th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.78
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.46%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.37
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,91,56330.3% delivered
Aarti Drugs share news and announcements
832 announcements, routine notices left out, newest first. Page 16 of 17.
Feb 2011
2 Feb · Dividend
Board of Directors of the Company at its Meeting held on February 02, 2011 have recommended dividend of Rs. 2.50 ps. (25%) per share on Equity Shares of Rs.10/- each fully paid up. The aforesaid Interim Dividend will be dispatched to registered members of the Company on February 15, 2011.
Jan 2011
19 Jan · Corporate action
Company has announced February 08, 2011 as the Record Date for the purpose of payment of interim dividend if any, declared. In case of approval of Interim Dividend by the Board of directors at its meeting held on February 02, 2011, the company will dispatch dividend warrants on February 15, 2011.19 Jan · Board meeting
Inter-alia to: 1) consider, approve and take on record the audited financial results and accounts for the quarter ended December 31, 2010. 2) Consider declaration of Interim Dividend, if any.17 Jan · Change in Company Secretary
Mr. Dilip Maharana, Company Secretary & Compliance Officer of the Company has resigned from the position of Company Secretary & Compliance Officer with effect from November 04, 2010. Further, Mr. Harshit M. Savla, Jt. Managing Director of the Company, has been appointed as Compliance Officer of the Company with effect from November 04, 2010.
Dec 2010
Nov 2010
Oct 2010
15 Oct · Board meeting
To consider, approve and take on record the audited financial results and accounts for the quarter & half year ended on September 30, 2010.
Sep 2010
Aug 2010
17 Aug · Updates
Subject to approval of the Members of Company pursuant to section 149(2A) of the Companies Act, 1956, the Company may consider to invest or participate by way of partnership, joint venture or otherwise in the business of building and/or development of properties, in the manner and at times when the opportunities are identified. Necessary approval of the Members to enable commencement of any of the said businesses, which can be conveniently and advantageously combined with the existing business, an Extra-ordinary General Meeting of the Company is being convened to be held on September 16, 2010.12 Aug · Management
Mr. Sudhirpraksh B. Sawant, Independent Director of the Company has resigned from the office of the Director of the Company with effect from July 30 2010. The registration has been duly accepted by the Board at its Meeting held on July 30,2010.5 Aug · Meeting
Transfer books and Register of members of Aarti Drugs Limited will be closed from August 21, 2010 to August 27, 2010 (both days inclusive) for the purpose of Annual General Meeting to be held on August 27, 2010 and declaration of dividend. Further in case of approval of Dividend by the Member, at the Annual General Meeting, the company shall commence dispatch of dividend warrants on or after September 02, 2010.
Jul 2010
28 Jul · Board meeting
Inter-alia, to consider, approve and take on record the audited financial results and accounts for the quarter ended June 30, 2010.16 Jul · Updates
Aarti Drugs Limited had informed the Exchange regarding closure of plant situated at Plot No.2902 & 2904, GIDC Sarigam, Valsad Dist. pursuant to direction of Gujarat Pollution Control Board (GPCB). The Company has now informed the Exchange that GPCB has revoked the Closure Order and the Company, as per the direction of GPCB, has started operation at the aforesaid plant w.e.f. July 15, 2010.
Jun 2010
25 Jun · Updates
Plant situated at plot No. 2902/2904, GIDC Sarigam, Valsad dist has been closed pursuant to Direction received from Gujarat Pollution Control Board (GPCB). The petition filed with the High Court of Gujarat, Ahmedabad, is pending for disposal. The operation of the said plant will be started subject to receipt of appropriate order of the said court or of clearance of appropriate authorities.
May 2010
26 May · Dividend
Board of Directors at its Meeting held on May 26, 2010 have recommended dividend of Rs. 5/- (50%) per share on 1,21,08,550 Equity Shares of Rs. 10/- each for the financial year 2009-2010.14 May · Board meeting
Interalia, to consider, approve and take on record the audited financial results and accounts for the quarter & year ended March 31, 2010 and to consider recommendation of dividend, if any.
Apr 2010
26 Apr · Results
Company will publish audited Financial Results for the financial year 2009-10, within 60 days from the end financial year i.e. on or before May 30, 2010. In view of the above the Company will not publish Unaudited Financial Result for the last quarter.
Jan 2010
14 Jan · Board meeting
To consider, approve and take on record the audited financial results and accounts for the quarter & nine months ended December 31, 2009.7 Jan · Updates
Aarti Drugs Ltd. has informed the Exchange that the Company is considering proposal for Capital Expenditure aggregating up to Rs.40 Crores by way of expansion / acquisition. This Capital Expenditure is to be funded by External Commercial Borrowing.
Dec 2009
23 Dec · Disclosure
Harshit M. Savla has informed the Exchange regarding the disclosure of shareholdings, pursuant to Regulations 7(1A) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 1997. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Dec · Disclosure
Aarti Drugs Ltd. has informed the Exchange regarding the disclosure of shareholdings in terms of Regulation 7(3) of SEBI (Substantial Acquisition Of Share & Takeover) Regulations, 1997. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Dec · Allotment of Equity Shares
Aarti Drugs Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on December 20, 2009, has allotted 4,00,000 equity shares of Rs.10/- each fully paid up against exercise of option of conversion by the holders of Convertible warrants issued by the Company on preferential basis to the promoters/promoter group companies and other persons in due compliance with the applicable SEBI DIP Guidelines and law. These convertible warrants were issued by the Company on 19.09.2008 at a price of Rs.52.60 ps. (including premium of Rs. 42.60 ps.) per share in due compliance of applicable SEBI DIP Guidelines. As a result of this, the Company's paid-up share capital has increased from Rs. 117085500/- to Rs.121085500/- divided into 12108550 equity shares of Rs.10/- each fully paid up.
Oct 2009
20 Oct · Board meeting
To consider, approve and take on record the audited financial results for the quarter & half year ended on September 30, 2009.
Aug 2009
3 Aug · Meeting
Aarti Drugs Ltd. has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Company held on August 01, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
30 Jul · Management
Aarti Drugs Ltd. has submitted to the Exchange the Auditor's Report in respect of the Audited Financial Results for the quarter ended June 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Jul · Change of address of Registrar & Share Transfer Agent
Aarti Drugs Ltd. has informed the Exchange that the Company's Share Registrar M/s. Sharepro Services (India) Pvt. Ltd. have changed their address. The same is as under: M/s. Sharepro Services (India) Pvt. Ltd., Samhita Warehousing Complex, Bldg. No. 13 A-B, Gala No. 52 to 56, Near Sakinaka Telephone Exchange, Andheri-Kurla Road, Sakinaka, Mumbai - 400 072; Tel No.: 022-67720300 / 67720400; Fax No.: 022-28591568 / 28508927; E-mail: Int@shareproservices.com17 Jul · Board meeting
To consider, approve and take on record the audited financial results and accounts for the quarter ended June 30, 2009.10 Jul · Meeting
Aarti Drugs Ltd. has informed the Exchange that the transfer books and Register of members of Aarti Drugs Limited will be closed from July 25, 2009 to August 1, 2009 (both days inclusive) for the purpose of Annual General Meeting to be held on August 1, 2009 and declaration of dividend. Further in case of approval of Dividend by the Member, at the Annual General Meeting, the company shall commence dispatch of dividend warrants on or after August 7, 2009.
May 2009
25 May · Management
Aarti Drugs Ltd. has submitted to the Exchange the Auditor's Report in respect of the Audited Financial Results for the quarter and year ended March 31, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 May · Dividend
Aarti Drugs Ltd. has informed the Exchange that the Board of Directors at their meeting held on May 20, 2009 has recommended Dividend of Rs. 3 per share (30%) on 1,17,08,550 Equity Shares of Rs. 10/- each fully paid up for the Financial year 2008-09.19 May · Management
Aarti Drugs Ltd. has informed the Exchange that Shri Dilip Maharana has been appointed as Company Secretary and Compliance Officer of the Company w.e.f. March 02, 2009.15 May · Management
Aarti Drugs Ltd. has informed the Exchange vide its letter dated May 15, 2009 that "The Board of Directors of the Company at its meeting held on October 20, 2008 has duly appointed Shri Krishnacharya Govindacharya Akamanchi & Prof. Sudhir Prakash B. Sawant as Independent Directors of the Company to comply with the amended clause 49 IA of the Listing Agreement vide SEBI circular no. SEBI/CFD/DIL/CG/1/2008/08/04."11 May · Board meeting
To transact, inter alia, the following business: [1] To consider and take on record the Audited Financial Results for the quarter and year ended March 31, 2009; [2] To consider recommendation of dividend, if any.4 May · Disclosure
Aarti Drugs Ltd. has submitted to the Exchange a copy of disclosure (Form B) in terms of regulation 13(2) of SEBI (Prohibition of Insider Trading) Regulations ,1992 have been received on May 04, 2009, from Shri. Sudhirprakash B. Sawant informing about the shares held before appointment as a Director of Company.A copy of Disclosure under Regulation 13 (2) of SEBI (PIT) Regulation, 1992 shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2009
15 Apr · Results
Aarti Drugs Ltd. has informed the Exchange that "The Company will publish audited Financial results for the financial year 2008-09 within 3 months i.e. on or before 30th June, 2009. In view of the above the Company will not publish Unaudited Financial Results for the last quarter."
Jan 2009
30 Jan · Management
Aarti Drugs Ltd. has submitted to the Exchange the auditor's report in respect of the audited financial results for the quarter ended December 31,2008.A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Jan · Board meeting
Company had informed the Exchange regarding the Board Meeting to be held on January 28, 2009 inter alia to consider and take on record audited financial results of the Company for the quarter ended December 31, 2008. The Company has now informed the Exchange that the date of the said Board meeting has now been changed to January 29, 2009 instead of January 28, 2009 inter alia to consider, approve and take on record the audited financial results of the Company for the quarter & nine months ended on December 31, 2008.10 Jan · Board meeting
To consider, approve and take on record the audited financial results and accounts for the quarter & nine months ended on December 31, 2008.
Oct 2008
7 Oct · Board meeting
To consider, approve and take on record the audited financial results and accounts for the quarter & half year ended on September 30, 2008.
Sep 2008
19 Sep · Issue and Allotment of warrants
Aarti Drugs Ltd. has informed the Exchange that pursuant to approval by way of Special resolution by the Company at its extra-ordinary general meeting held on September 05, 2008 and in accordance with In-principle approvals granted by the Exchanges and due compliance with the applicable SEBI Guidelines for Preferential Issue, the Board of Directors of the Company have issued and allotted on September 19, 2008, 4,00,000 convertible warrants on preferential basis to promoters/promoters group companies. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.